Chemoinformaics analysis of 4-Hydroxy-2-isopropenyl-5-methylhex-5-enyl 2-methylbutyrate
| Molecular Weight | 254.37 | nRot | 8 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 3 |
| Exact Molecular Weight | 254.188 | nRing | 0 |
| Solubility: LogS | -2.615 | nHRing | 0 |
| Solubility: LogP | 3.09 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 44.7926 |
| nHD | 1 | BPOL | 28.6874 |
| QED | 0.535 |
| Synth | 4 |
| Natural Product Likeliness | 1.638 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.012 |
| HIA | 0.009 |
| CACO-2 | -4.378 |
| MDCK | 0.0000199 |
| BBB | 0.401 |
| PPB | 0.520135 |
| VDSS | 1.153 |
| FU | 0.525348 |
| CYP1A2-inh | 0.064 |
| CYP1A2-sub | 0.154 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.842 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.268 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.545 |
| CYP3a4-inh | 0.044 |
| CYP3a4-sub | 0.341 |
| CL | 11.12 |
| T12 | 0.347 |
| hERG | 0.038 |
| Ames | 0.013 |
| ROA | 0.034 |
| SkinSen | 0.061 |
| Carcinogencity | 0.125 |
| EI | 0.46 |
| Respiratory | 0.851 |
| NR-Aromatase | 0.007 |
| Antiviral | Yes |
| Prediction | 0.772382 |